• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑脊液过滤是治疗吉兰-巴雷综合征的一种有效疗法:一项随机临床试验。

CSF filtration is an effective treatment of Guillain-Barré syndrome: a randomized clinical trial.

作者信息

Wollinsky K H, Hülser P J, Brinkmeier H, Aulkemeyer P, Bössenecker W, Huber-Hartmann K H, Rohrbach P, Schreiber H, Weber F, Kron M, Büchele G, Mehrkens H H, Ludolph A C, Rüdel R

机构信息

Department of Anesthesiology/Intensive Care, Rehabilitation Hospital Ulm, Germany.

出版信息

Neurology. 2001 Sep 11;57(5):774-80. doi: 10.1212/wnl.57.5.774.

DOI:10.1212/wnl.57.5.774
PMID:11552002
Abstract

OBJECTIVE

To compare CSF filtration (CSFF) and plasma exchange (PE) in the treatment of patients with Guillain-Barré syndrome (GBS).

METHODS

In a prospective controlled clinical trial, 37 patients with acute GBS were randomized to receive either CSFF or PE. Inclusion criteria were fulfillment of National Institute of Neurological and Communicative Disorders and Stroke criteria and disability to walk >5 m unassisted.

RESULTS

With similar baseline features in both groups (initial disability grades on the six-point grading scale of the GBS Study Group) the primary outcome variable (improvement within 28 days after randomization) was almost identical (test for equivalence p = 0.0014), the mean grade values being 0.82 in the CSFF group and 0.80 in the PE group. After 56 days, 56% (9 of 16 patients) of the CSFF group and 37% (7 of 19 patients) of the PE group had reached grade 2 (i.e., ability of unassisted walking >5 m). After 6 months, the probability to reach grade 2 was about 80% in both groups. In the CSFF group, transient pleocytosis occurred without apparent clinical complications. Clinically relevant complications were higher in the PE-treated group.

CONCLUSIONS

Although the number of patients was small, the authors found that the treatment of GBS with CSFF is at least as effective as with PE. CSFF might work by removing from the CSF inflammatory mediators, autoantibodies, or other factors.

摘要

目的

比较脑脊液滤过(CSFF)和血浆置换(PE)治疗吉兰-巴雷综合征(GBS)患者的效果。

方法

在一项前瞻性对照临床试验中,37例急性GBS患者被随机分为接受CSFF或PE治疗两组。纳入标准为符合美国国立神经疾病与卒中研究所标准且无法独立行走超过5米。

结果

两组基线特征相似(GBS研究组六点分级量表初始残疾等级),主要结局变量(随机分组后28天内的改善情况)几乎相同(等效性检验p = 0.0014),CSFF组平均等级值为0.82,PE组为0.80。56天后,CSFF组56%(16例中的9例)和PE组37%(19例中的7例)达到2级(即能够独立行走超过5米)。6个月后,两组达到2级的概率约为80%。CSFF组出现短暂性细胞增多症,但无明显临床并发症。PE治疗组临床相关并发症较多。

结论

尽管患者数量较少,但作者发现CSFF治疗GBS至少与PE一样有效。CSFF可能通过清除脑脊液中的炎症介质、自身抗体或其他因素发挥作用。

相似文献

1
CSF filtration is an effective treatment of Guillain-Barré syndrome: a randomized clinical trial.脑脊液过滤是治疗吉兰-巴雷综合征的一种有效疗法:一项随机临床试验。
Neurology. 2001 Sep 11;57(5):774-80. doi: 10.1212/wnl.57.5.774.
2
Plasma exchange for Guillain-Barré syndrome.用于吉兰-巴雷综合征的血浆置换
Cochrane Database Syst Rev. 2002(2):CD001798. doi: 10.1002/14651858.CD001798.
3
Plasma exchange versus double filtration plasmapheresis in the treatment of Guillain-Barré syndrome.血浆置换与双重滤过血浆置换治疗吉兰-巴雷综合征的比较。
Ther Apher. 2002 Apr;6(2):163-6. doi: 10.1046/j.1526-0968.2002.00382.x.
4
[CSF filtration and interferon-beta for Guillain-Barré syndrome].
Nihon Rinsho. 2008 Jun;66(6):1200-4.
5
Tryptophan-immobilized column-based immunoadsorption as the choice method for plasmapheresis in Guillain-Barré syndrome.基于色氨酸固定化柱的免疫吸附作为吉兰-巴雷综合征血浆置换的选择方法。
Ther Apher Dial. 2004 Jun;8(3):248-53. doi: 10.1111/j.1526-0968.2004.00138.x.
6
Small volume plasma exchange for Guillain-Barré syndrome in resource-limited settings: a phase II safety and feasibility study.资源受限环境下小容量血浆置换治疗吉兰-巴雷综合征:一项II期安全性和可行性研究。
BMJ Open. 2018 Aug 17;8(8):e022862. doi: 10.1136/bmjopen-2018-022862.
7
Filtration of cerebrospinal fluid in acute inflammatory demyelinating polyneuropathy (Guillain-Barré syndrome).
Ann Med Interne (Paris). 1994;145(7):451-8.
8
Plasma exchange for Guillain-Barré syndrome.用于吉兰-巴雷综合征的血浆置换
Cochrane Database Syst Rev. 2001(2):CD001798. doi: 10.1002/14651858.CD001798.
9
Intravenous immunoglobulin for Guillain-Barré syndrome.静脉注射免疫球蛋白治疗吉兰-巴雷综合征。
Cochrane Database Syst Rev. 2001(2):CD002063. doi: 10.1002/14651858.CD002063.
10
Plasma exchange after initial intravenous immunoglobulin treatment in Guillain-Barré syndrome: critical reassessment of effectiveness and cost-efficiency.吉兰-巴雷综合征初始静脉注射免疫球蛋白治疗后进行血浆置换:对有效性和成本效益的批判性重新评估
J Clin Neuromuscul Dis. 2010 Dec;12(2):55-61. doi: 10.1097/CND.0b013e3181f3dbbf.

引用本文的文献

1
Molecular, Electrophysiological, and Ultrasonographic Differences in Selected Immune-Mediated Neuropathies with Therapeutic Implications.具有治疗意义的特定免疫介导性神经病的分子、电生理和超声差异。
Int J Mol Sci. 2023 May 24;24(11):9180. doi: 10.3390/ijms24119180.
2
Apolipoprotein B-100-mediated motor neuron degeneration in sporadic amyotrophic lateral sclerosis.载脂蛋白B - 100介导的散发性肌萎缩侧索硬化症中的运动神经元变性。
Brain Commun. 2022 Aug 22;4(4):fcac207. doi: 10.1093/braincomms/fcac207. eCollection 2022.
3
Efficacy of therapies in the treatment of Guillain-Barre syndrome: A network meta-analysis.
治疗吉兰-巴雷综合征的疗效:网状荟萃分析。
Medicine (Baltimore). 2021 Oct 15;100(41):e27351. doi: 10.1097/MD.0000000000027351.
4
The Challenge of Assessing Mild Neuroinflammation in Severe Mental Disorders.评估严重精神障碍中轻度神经炎症的挑战
Front Psychiatry. 2020 Aug 20;11:773. doi: 10.3389/fpsyt.2020.00773. eCollection 2020.
5
Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barré syndrome.吉兰-巴雷综合征除皮质类固醇、静脉注射免疫球蛋白和血浆置换之外的药物治疗。
Cochrane Database Syst Rev. 2020 Jan 25;1(1):CD008630. doi: 10.1002/14651858.CD008630.pub5.
6
Wild-type Cu/Zn-superoxide dismutase is misfolded in cerebrospinal fluid of sporadic amyotrophic lateral sclerosis.野生型铜锌超氧化物歧化酶在散发性肌萎缩侧索硬化症的脑脊液中错误折叠。
Mol Neurodegener. 2019 Nov 19;14(1):42. doi: 10.1186/s13024-019-0341-5.
7
Immunotherapy of Guillain-Barré syndrome.格林-巴利综合征的免疫治疗。
Hum Vaccin Immunother. 2018;14(11):2568-2579. doi: 10.1080/21645515.2018.1493415. Epub 2018 Jul 12.
8
Implantable Systems for Continuous Liquorpheresis and CSF Replacement.用于连续脑脊液分离和脑脊液置换的植入式系统。
Cureus. 2017 Feb 10;9(2):e1022. doi: 10.7759/cureus.1022.
9
Plasma exchange for Guillain-Barré syndrome.用于吉兰-巴雷综合征的血浆置换
Cochrane Database Syst Rev. 2017 Feb 27;2(2):CD001798. doi: 10.1002/14651858.CD001798.pub3.
10
Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barré syndrome.除皮质类固醇、静脉注射免疫球蛋白和血浆置换外,用于吉兰-巴雷综合征的药物治疗。
Cochrane Database Syst Rev. 2016 Nov 15;11(11):CD008630. doi: 10.1002/14651858.CD008630.pub4.